InVivoMAb anti-human EGFR

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint. Koopmans I et al., 2018, Oncoimmunology

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer. van Gog FB et al., 1998 Jul 3, Int J Cancer

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Rubin Grandis J et al., 1997 Jul 24, Oncogene

Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Murthy U et al., 1987 Feb 1, Arch Biochem Biophys

Inhibition of TGF alpha-induced second messengers by anti-EGF receptor antibody-425. Murthy U et al., 1990 Oct 30, Biochem Biophys Res Commun